Evidence map›Paper›PMID 31685468›Full record

Trial reportAntimicrobial agents and chemotherapy2019

Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis during Acute Pulmonary Exacerbation.

James M Kidd, Colleen M Sakon, Louise-Marie Oleksiuk, Jeffrey J Cies, Rebecca S Pettit, David P Nicolau, Joseph L Kuti

Open access · bronzeAbstract readClinical TrialMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

James M KiddCenter for Anti-Infective Research and Development, Hartford Hospital, Harford, Connecticut, USA.
Colleen M SakonIndiana University Health, Indianapolis, Indiana, USA.
Louise-Marie OleksiukUPMC Presbyterian Shadyside Hospital, Pittsburgh, Pennsylvania, USA.
Jeffrey J CiesSt. Christopher's Hospital for Children, Philadelphia, Pennsylvania, USA.
Rebecca S PettitRiley Hospital for Children, Indianapolis, Indiana, USA.
David P NicolauCenter for Anti-Infective Research and Development, Hartford Hospital, Harford, Connecticut, USA.
Joseph L KutiCenter for Anti-Infective Research and Development, Hartford Hospital, Harford, Connecticut, USA joseph.kuti@hhchealth.org.
Hartford Hospital · USIndiana University – Purdue University Indianapolis · USRiley Hospital for Children · USShadyside Hospital · USSt. Christopher's Hospital for Children · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adults with cystic fibrosis (CF) frequently harbor

Indexed as

AdultAlgorithmsAminoglycosidesAnti-Bacterial AgentsCystic FibrosisFemaleHumansLipoglycopeptidesMaleMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMiddle AgedMonte Carlo MethodProspective StudiesStaphylococcal InfectionsAminoglycosidesAnti-Bacterial AgentsLipoglycopeptidestelavancinacute pulmonary exacerbationcystic fibrosisdoseglycopeptidesMonte Carlo simulationpharmacokineticsprobability of target attainmenttelavancin

Identifiers

PMID31685468
PMCPMC7187619
OpenAlexW2989101389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.